bridgewest lidocaine injection 2% 100 mg/5 ml solution for injection ampoule
bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.
aspen adrenaline
pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline 1mg; - solution for injection - 1mg/10ml - active: adrenaline 1mg excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite tartaric acid water for injection - adrenaline 1:10,000. an adjunct in the management of cardiac arrest.
noradrenaline bnm
boucher & muir (new zealand) limited t/a bnm group - noradrenaline acid tartrate 2 mg/ml equivalent to 1 mg/ml noradrenaline base; - concentrate for injection - 1 mg/ml - active: noradrenaline acid tartrate 2 mg/ml equivalent to 1 mg/ml noradrenaline base excipient: nitrogen sodium chloride water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusions and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.
adrenaline jr viatris adrenaline (epinephrine) 0.15 mg/0.3 ml injection syringe auto-injector
alphapharm pty ltd - adrenaline (epinephrine), quantity: 0.5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. adrenaline mylan and adrenaline jr mylan are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens.
adrenaline viatris adrenaline (epinephrine) 0.3 mg/0.3 ml injection syringe auto-injector
alphapharm pty ltd - adrenaline (epinephrine), quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid - for the emergency treatment of anaphylactic reactions to insect stings through immediate self administration by individuals with a history of hypersensitivity to insect stings. adrenaline mylan and adrenaline jr mylan are designated as emergency supportive therapy only and are not a replacement or substitute for subsequent medical or hospital care, nor are they intended to supplant insect venom hyposensitization. indications as at 17 june 2003: for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, drugs or other allergens.
adrenaline aguettant 1:10,000 adrenaline (epinephrine) (as acid tartrate) 1 mg/10 ml solution for injection prefilled syringe
juno pharmaceuticals pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 1.819 mg (equivalent: adrenaline (epinephrine), qty 1 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - adrenaline aguettant 1:10,000 is used as an adjunct in the management of cardiac arrest.
adrenaline injection
medisel kenya ltd p.o box 540-01000 thika - adrenaline - injection - adrenaline 1mg/ml - cardiac stimulants excluding cardiac glycosides:
adrenaline injection
dawa limited p.o box 16633-00620 nairobi-kenya - adrenaline - injection - adrenaline bp 1.0mg/1ml - cardiac stimulants excluding cardiac glycosides:
adrenaline injection
laboratory & allied ltd p.o box 42875-00100 nairobi - adrenaline - injection - adrenaline 0.1% - cardiac stimulants excluding cardiac glycosides:
marcain 0.25% with adrenaline (epinephrine) 1:400,000 20ml injection vial
aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 4.5 microgram/ml (equivalent: adrenaline (epinephrine), qty 2.5 microgram/ml); bupivacaine hydrochloride, quantity: 2.5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 2.64 mg/ml) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia; epidural block for surgery, field block (minor and major nerve blocks and infiltration). analgesia; continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. field block (minor nerve block and infiltration). the choice of 4 strengths, 0.125%, 0.25%, 0.375% and 0.5%, makes it possible to vary the degree of motor blockade.